Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Revenue

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹31,724 Cr₹29,002 Cr₹24,855 Cr₹23,455 Cr₹24,775 Cr

What is the latest Revenue of AUROBINDO PHARMA ?

The latest Revenue ratio of AUROBINDO PHARMA is ₹31,724 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹31,724 Cr
Mar2024₹29,002 Cr
Mar2023₹24,855 Cr
Mar2022₹23,455 Cr
Mar2021₹24,775 Cr

How is Revenue of AUROBINDO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹31,724 Cr
9.39
Mar2024 ₹29,002 Cr
16.68
Mar2023 ₹24,855 Cr
5.97
Mar2022 ₹23,455 Cr
-5.32
Mar2021 ₹24,775 Cr -

Compare Revenue of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹68,107.5 Cr -4.8% 0% -6.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,728.0 Cr -1.3% -3.9% -5.8% Stock Analytics
DIVIS LABORATORIES ₹172,248.0 Cr -2.3% 0.9% 12.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,627.0 Cr 0.3% 3.9% 19.2% Stock Analytics
CIPLA ₹118,423.0 Cr -4.2% -3.1% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,462.0 Cr -3.2% -4.5% -11.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-4.8%

0%

-6.5%

SENSEX

-1.8%

-0.6%

7.3%


You may also like the below Video Courses